Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492011.RAuN3vIXfOZuI1XEcxEJYkfdo_aBd8jCbkrutOyUdhrqg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492011.RAuN3vIXfOZuI1XEcxEJYkfdo_aBd8jCbkrutOyUdhrqg130_assertion type Assertion NP492011.RAuN3vIXfOZuI1XEcxEJYkfdo_aBd8jCbkrutOyUdhrqg130_head.
- NP492011.RAuN3vIXfOZuI1XEcxEJYkfdo_aBd8jCbkrutOyUdhrqg130_assertion description "[GM-CSF and IL-2 induce tumor rejection in animal models when expressed by tumor cells, and IL-2 is used for the treatment of melanoma and renal cell cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492011.RAuN3vIXfOZuI1XEcxEJYkfdo_aBd8jCbkrutOyUdhrqg130_provenance.
- NP492011.RAuN3vIXfOZuI1XEcxEJYkfdo_aBd8jCbkrutOyUdhrqg130_assertion evidence source_evidence_literature NP492011.RAuN3vIXfOZuI1XEcxEJYkfdo_aBd8jCbkrutOyUdhrqg130_provenance.
- NP492011.RAuN3vIXfOZuI1XEcxEJYkfdo_aBd8jCbkrutOyUdhrqg130_assertion SIO_000772 16483188 NP492011.RAuN3vIXfOZuI1XEcxEJYkfdo_aBd8jCbkrutOyUdhrqg130_provenance.
- NP492011.RAuN3vIXfOZuI1XEcxEJYkfdo_aBd8jCbkrutOyUdhrqg130_assertion wasDerivedFrom befree-20150227 NP492011.RAuN3vIXfOZuI1XEcxEJYkfdo_aBd8jCbkrutOyUdhrqg130_provenance.
- NP492011.RAuN3vIXfOZuI1XEcxEJYkfdo_aBd8jCbkrutOyUdhrqg130_assertion wasGeneratedBy ECO_0000203 NP492011.RAuN3vIXfOZuI1XEcxEJYkfdo_aBd8jCbkrutOyUdhrqg130_provenance.